On Monday, Atyr Pharma Inc (NASDAQ: ATYR) opened higher 4.34% from the last session, before settling in for the closing price of $5.3. Price fluctuations for ATYR have ranged from $1.58 to $5.98 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 34.28% annually for the last half of the decade. Company’s average yearly earnings per share was noted 28.86% at the time writing. With a float of $86.06 million, this company’s outstanding shares have now reached $89.00 million.
In an organization with 59 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atyr Pharma Inc (ATYR) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Atyr Pharma Inc is 3.31%, while institutional ownership is 68.68%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 28.86% per share during the next fiscal year.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Check out the current performance indicators for Atyr Pharma Inc (ATYR). In the past quarter, the stock posted a quick ratio of 7.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Let’s dig in a bit further. During the last 5-days, its volume was 3.36 million. That was better than the volume of 1.84 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 71.21%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 87.77%, which indicates a significant decrease from 92.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.40 in the past 14 days, which was higher than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.54, while its 200-day Moving Average is $3.57. However, in the short run, Atyr Pharma Inc’s stock first resistance to watch stands at $5.65. Second resistance stands at $5.78. The third major resistance level sits at $5.98. If the price goes on to break the first support level at $5.32, it is likely to go to the next support level at $5.12. Assuming the price breaks the second support level, the third support level stands at $4.99.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are currently 89,004K shares outstanding in the company with a market cap of 492.19 million. Presently, the company’s annual sales total 240 K according to its annual income of -64,020 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -14,880 K.
